Cancer Care

May 14, 2008

Ultraviolet radiation can give you cancer. It’s a fact

The first argues that a tan is the body’s natural protection against sunburn. The second informs me that the rate of melanoma in the United States has doubled in the last 30 years.

I would like to know who is behind the first, which advocates rediscovering the sun, but the site does not tell me. Here’s a hint though: There’s a tanning salon locator at the top of the page.

The second? The World Health Organization.

Dr. David J. Leffell, a professor of dermatology and surgery at Yale University School of Medicine, is blunt about where he stands.
(more…)

Skin Cancer Month

It’s hard to avoid the Florida sunshine, but health experts warn everyone to limit sun exposure.

That’s because skin cancer is the most common form of cancer in the United States with more than a million people diagnosed annually.

Tallahassee resident, Susanne Murphy noticed a lesion on her arm, and immediately went to her dermatologist where she learned she had melanoma.

Doctors say they are seeing more cases like Murphy’s. This form of skin cancer kills 8,000 people a year.

Susanne Murphy said, “Early detection is critical and early treatment is critical, if anybody has a suspicious lesion or spot on their body, immediately go to a dermatologist, it could save your life.”

Doctors say people can take precautions to avoid many skin cancers including:
-applying daily moisturizer with SPF 30 or higher
-cover up with clothing including a hat
-and wear UV-blocking sunglasses
-avoiding peak sun times

Source : www.wctv.tv

Tanning Beds May Cause Skin Cancer

* The number of skin cancers occurring in the population under 35 years old has risen sharply in the last few years. One of the reasons for this, without a doubt, is the inadequate and indiscriminate use of tanning beds, revealed doctor Felipa Cotzomi Atzompa, a dermatologist appointed at the General Regional Hospital (HGR, in Spanish) Number 36 “San Alejandro” at the Mexican Institute of Social Security (IMSS, in Spanish) in Puebla.

“Over 30 sessions a year constitute a real danger, and over 50 can cause from premature ageing to skin melanoma”, she asserted.
(more…)

Skin cancer trek a memorial to father

MILFORD — Sherrill Cooke is a woman on a mission.

The fifth annual Bob Cooke Memorial Trek Against Skin Cancer, which will be held Sunday, is now just the centerpiece of a year-long effort to raise awareness of and funding for the disease that claimed her father’s life.

There will be a “shopping day” June 14 at the Blue Tulip, from which a portion of the profits will be donated to the Bob Cooke Skin Cancer Foundation and a masquerade ball later this summer. In the fall, the foundation will hold a second annual event in Florida.
(more…)

Tooth Loss Strongly Linked To Risk Of Esophageal, Head And Neck, And Lung Cancer

In the May issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research, scientists from Aichi Cancer Center in Nagoya and Nagoya University Graduate School of Medicine speculate that bacterial infection and inflammation resulting from poor oral care that leads to tooth loss could also be driving development of these cancers. Periodontal disease is known to increase risk for stroke and heart disease.
(more…)

WASHINGTON (Reuters) - A protein responsible for repairing damaged DNA may be a vital link to explaining how smoking causes lung cancer, U.S. researchers reported on Tuesday.

Cancer care, health careA CANCER survivor will be celebrating his recovery when he runs to raise money for research into the disease.

Graham Swan, who is taking part in the BUPA Great Manchester Run on Sunday, was diagnosed with lung cancer just one week after he ran in the 10km event last year.

The father of two said it hit his family like a `bolt out of the blue’ when doctors found a tumour the size of a golf ball in his right lung during an x-ray.

He had an operation to remove it and was out of action for three months.

But Graham says he is lucky it was discovered early and now he wants to spread the message that early detection is `the best cure’.

He hopes to raise at least £500 for Cancer Research UK by running the race.

Engineer Graham, 45, from Dukinfield, said: “When I got ill I set myself a target to run in the race again this year.”

Researchers find smoking-lung cancer culprit

WASHINGTON (Reuters) - A protein responsible for repairing damaged DNA may be a vital link to explaining how smoking causes lung cancer, U.S. researchers reported on Tuesday.

Lung cells exposed to cigarette smoke produce less of the protein, called FANCD2, the team at Oregon Health & Science University Cancer Institute reported.

Without FANCD2, damaged DNA can cause cells to proliferate out of control instead of destroying themselves as normal cells do.
(more…)

Tooth Loss Strongly Linked To Risk Of Esophageal, Head And Neck, And Lung Cancer

In the May issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research, scientists from Aichi Cancer Center in Nagoya and Nagoya University Graduate School of Medicine speculate that bacterial infection and inflammation resulting from poor oral care that leads to tooth loss could also be driving development of these cancers. Periodontal disease is known to increase risk for stroke and heart disease.
(more…)

Canadian cancer statistics 2008

New Brunswick - More Canadian children with cancer are surviving, according to Canadian Cancer Statistics 2008 released by the Canadian Cancer Society. For all childhood cancers combined, the five-year survival rate is estimated to be 82 per cent — an increase of 11 per cent over 15 years.

“Increased survival rates are obviously good news for everyone,” said Anne McTiernan-Gamble, Executive Director of the Canadian Cancer Society, New Brunswick, in a press release.
(more…)

Cleveland BioLabs Completes Recruitment for Prostate Cancer Trial

Cleveland BioLabs has enrolled all the patients in its Phase II clinical trial of Curaxin CBLC102 in advanced, hormone-refractory prostate cancer.

Thirty-two patients from four medical centers in the U.S. will be evaluated prior to treatment with the drug, as well as at one-month intervals for a maximum of six months.

The trial’s goals are to confirm safety and tolerability of the drug in patients with hormone-refractory metastatic prostate cancer and to evaluate the efficacy of the drug by assessing prostate-specific antigen levels, reductions in tumor size and disease-free survival periods.

The company said it expects results to be available in the fourth quarter of this year.

Source : fdanews.co

Get free blog up and running in minutes with Blogsome
Theme designed by Ian Main